Career history of Christopher Friedel
Former positions of Christopher Friedel
| Companies | Position | Start | End |
|---|---|---|---|
| APONTIS PHARMA AG | Director/Board Member | 31/12/2020 | 11/05/2022 |
Jazz Pharmaceuticals Germany GmbH
 Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Chief Executive Officer | 30/11/2020 | - |
Training of Christopher Friedel
| University of Gottingen | Doctorate Degree |
Statistics
International
| Germany | 4 |
Operational
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Private companies | 1 |
|---|---|
Jazz Pharmaceuticals Germany GmbH
Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Health Technology |
- Stock Market
- Insiders
- Christopher Friedel
- Experience
